Literature DB >> 25132671

Development of an autoimmune syndrome affecting the skin and internal organs in P-selectin glycoprotein ligand 1 leukocyte receptor-deficient mice.

A Pérez-Frías1, R González-Tajuelo, N Núñez-Andrade, R Tejedor, M J García-Blanco, E Vicente-Rabaneda, S Castañeda, C Gamallo, J Silván, A Esteban-Villafruela, L Cubero-Rueda, C García-García, C Muñoz-Calleja, A García-Diez, A Urzainqui.   

Abstract

OBJECTIVE: To define and characterize the progression of the spontaneous autoimmune disease that develops in mice in the absence of the leukocyte adhesion receptor P-selectin glycoprotein ligand 1 (PSGL-1).
METHODS: Skin-resident immune cells from PSGL-1-deficient mice and C57BL/6 control mice of different ages were isolated and analyzed by flow cytometry. Biochemical parameters were analyzed in mouse serum and urine, and the presence of serum autoantibodies was investigated. Skin and internal organs were extracted, and their structure was analyzed histologically.
RESULTS: Skin-resident innate and adaptive immune cells from PSGL-1(-/-) mice had a proinflammatory phenotype with an imbalanced T effector cell:Treg cell ratio. Sera from PSGL-1(-/-) mice had circulating autoantibodies commonly detected in connective tissue-related human autoimmune diseases. Biochemical and histologic analysis of skin and internal organs revealed skin fibrosis and structural and functional abnormalities in the lungs and kidneys. Furthermore, PSGL-1(-/-) mice exhibited vascular alterations, showing loss of dermal vessels, small vessel medial layer remodeling in the lungs and kidneys, and ischemic processes in the kidney that promote renal infarcts.
CONCLUSION: Our study demonstrates that immune system overactivation due to PSGL-1 deficiency triggers an autoimmune syndrome with characteristics similar to systemic sclerosis, including skin fibrosis, vascular alterations, and systemic organ involvement. These results suggest that PSGL-1 expression contributes to the maintenance of the homeostasis of the immune system and could act as a barrier for autoimmunity in mice.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25132671     DOI: 10.1002/art.38808

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  10 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 2.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 3.  Sialic acids and autoimmune disease.

Authors:  Vinay S Mahajan; Shiv Pillai
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

4.  Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.

Authors:  Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Monique L Henriquez; Christian F Guerrero-Juarez; Roberto Tinoco
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

5.  VISTA is an acidic pH-selective ligand for PSGL-1.

Authors:  Linhui Julie Su; Jason Pinckney; David Critton; Robert J Johnston; Eric Boyer; Arathi Krishnakumar; Martin Corbett; Andrew L Rankin; Rose Dibella; Lynne Campbell; Gaelle H Martin; Hadia Lemar; Thomas Cayton; Richard Y-C Huang; Xiaodi Deng; Akbar Nayeem; Haibin Chen; Burce Ergel; Joseph M Rizzo; Aaron P Yamniuk; Sanjib Dutta; Justine Ngo; Andrea Olga Shorts; Radha Ramakrishnan; Alexander Kozhich; Jim Holloway; Hua Fang; Ying-Kai Wang; Zheng Yang; Kader Thiam; Ginger Rakestraw; Arvind Rajpal; Paul Sheppard; Michael Quigley; Keith S Bahjat; Alan J Korman
Journal:  Nature       Date:  2019-10-23       Impact factor: 49.962

6.  P-Selectin preserves immune tolerance in mice and is reduced in human cutaneous lupus.

Authors:  Rafael González-Tajuelo; Javier Silván; Alicia Pérez-Frías; María de la Fuente-Fernández; Reyes Tejedor; Marina Espartero-Santos; Esther Vicente-Rabaneda; Ángeles Juarranz; Cecilia Muñoz-Calleja; Santos Castañeda; Carlos Gamallo; Ana Urzainqui
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

7.  Relevance of PSGL-1 Expression in B Cell Development and Activation.

Authors:  Rafael González-Tajuelo; Elena González-Sánchez; Javier Silván; Antonio Muñoz-Callejas; Esther Vicente-Rabaneda; Javier García-Pérez; Santos Castañeda; Ana Urzainqui
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 8.  PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy.

Authors:  Julia M DeRogatis; Karla M Viramontes; Emily N Neubert; Roberto Tinoco
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

9.  In-silico analysis of interacting pathways through KIM-1 protein interaction in diabetic nephropathy.

Authors:  F Abid; Z Rubab; S Fatima; A Qureshi; A Azhar; A Jafri
Journal:  BMC Nephrol       Date:  2022-07-18       Impact factor: 2.585

10.  Spontaneous Pulmonary Hypertension Associated With Systemic Sclerosis in P-Selectin Glycoprotein Ligand 1-Deficient Mice.

Authors:  Rafael González-Tajuelo; María de la Fuente-Fernández; Daniel Morales-Cano; Antonio Muñoz-Callejas; Elena González-Sánchez; Javier Silván; Juan Manuel Serrador; Susana Cadenas; Bianca Barreira; Marina Espartero-Santos; Carlos Gamallo; Esther F Vicente-Rabaneda; Santos Castañeda; Francisco Pérez-Vizcaíno; Ángel Cogolludo; Luis Jesús Jiménez-Borreguero; Ana Urzainqui
Journal:  Arthritis Rheumatol       Date:  2020-01-28       Impact factor: 10.995

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.